WO2001041794A3 - Activated amylase - Google Patents

Activated amylase Download PDF

Info

Publication number
WO2001041794A3
WO2001041794A3 PCT/FR2000/003445 FR0003445W WO0141794A3 WO 2001041794 A3 WO2001041794 A3 WO 2001041794A3 FR 0003445 W FR0003445 W FR 0003445W WO 0141794 A3 WO0141794 A3 WO 0141794A3
Authority
WO
WIPO (PCT)
Prior art keywords
amylase
calcium salt
alpha
activated
activated amylase
Prior art date
Application number
PCT/FR2000/003445
Other languages
French (fr)
Other versions
WO2001041794A2 (en
Inventor
Jean Chatillon
Paul Chislain Coupan
Murielle Trinquier
Original Assignee
Top Pharm Lab
Jean Chatillon
Paul Chislain Coupan
Murielle Trinquier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Top Pharm Lab, Jean Chatillon, Paul Chislain Coupan, Murielle Trinquier filed Critical Top Pharm Lab
Priority to AU25251/01A priority Critical patent/AU2525101A/en
Publication of WO2001041794A2 publication Critical patent/WO2001041794A2/en
Publication of WO2001041794A3 publication Critical patent/WO2001041794A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to a novel composition which is characterized in that it contains alpha-amylase and a calcium salt. The enzymatic activity of the amylase is considerably increased and prolonged by several weeks when the amylase and the calcium salt are present in specified relative concentrations. The alpha-amylase is advantageously produced by Bacillus amyloliquefaciens. The calcium salt is especially calcium chloride.
PCT/FR2000/003445 1999-12-10 2000-12-08 Activated amylase WO2001041794A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU25251/01A AU2525101A (en) 1999-12-10 2000-12-08 Activated amylase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9915604A FR2802100B1 (en) 1999-12-10 1999-12-10 ACTIVATED AMYLASE
FR99/15604 1999-12-10

Publications (2)

Publication Number Publication Date
WO2001041794A2 WO2001041794A2 (en) 2001-06-14
WO2001041794A3 true WO2001041794A3 (en) 2002-09-12

Family

ID=9553114

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2000/003445 WO2001041794A2 (en) 1999-12-10 2000-12-08 Activated amylase

Country Status (3)

Country Link
AU (1) AU2525101A (en)
FR (1) FR2802100B1 (en)
WO (1) WO2001041794A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2908998A1 (en) * 2006-11-24 2008-05-30 Bao Quoc Ho Use of enzyme concentrate from cereal germ for therapeutic purposes to manufacture an anti inflammatory drug to treat arthritis and osteoarthritis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956483A (en) * 1968-10-24 1976-05-11 Wilson Pharmaceutical & Chemical Corporation Preparing pancreatin
KR920002161B1 (en) * 1988-04-27 1992-03-19 조선무약 합자회사 Agent of diabetes and process for preparing a dietary fiber

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956483A (en) * 1968-10-24 1976-05-11 Wilson Pharmaceutical & Chemical Corporation Preparing pancreatin
KR920002161B1 (en) * 1988-04-27 1992-03-19 조선무약 합자회사 Agent of diabetes and process for preparing a dietary fiber

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 199303, Derwent World Patents Index; Class B04, AN 1993-024735, XP002145868 *

Also Published As

Publication number Publication date
FR2802100A1 (en) 2001-06-15
FR2802100B1 (en) 2003-03-21
AU2525101A (en) 2001-06-18
WO2001041794A2 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
DK1162995T3 (en) Enzymes for the treatment of type I diabetes mellitus
WO2005111203A3 (en) MUTANT α ΑMYLASES
BG103977A (en) Low molecular rotamase enzymic activity inhibitors
WO2001062280A3 (en) Lipase-containing composition and methods of use thereof
ATE103632T1 (en) ENZYMATIC DETERGENT COMPOSITION AND METHOD OF STABILIZING THE ENZYMES.
DE69739558D1 (en) MODIFIED alpha-AMYLASES WITH CHANGED CALCIUM-BINDING PROPERTIES
WO2007044993A3 (en) Use and production of storage-stable neutral metalloprotease
NZ311274A (en) Mutant alpha-amylase
ATE274588T1 (en) MUTANT ALPHA-AMYLASE WITH ADDITIONAL DISULFIDE COMPOUND
CA2411373A1 (en) Stable liquid enzyme compositions with enhanced activity
AU2002233186A1 (en) Cyclodextrin glucanotransferase (cgtase), obtained from bacillus agaradherens (dsm 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase
NO20021550D0 (en) Enzymes useful for altering the properties of polyester
WO1999029876A3 (en) Mutant bacillus licheniformis alpha-amylase
MY129850A (en) Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
WO2004042351A3 (en) Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
CA2318398A1 (en) Novel peptides having biological activity
AU8334501A (en) Cyclopentyl modulators of chemokine receptor activity
WO2003049550A3 (en) Animal feed
AU8173698A (en) Improved starch purification by thermally tolerant broad ph range proteolytic enzymes
AU7903400A (en) Selective inhibitors of the urokinase plasminogene activators
AU7934500A (en) The treatment of wounds
ZA963900B (en) Use of mannasases as slime control agents
WO2000050631A3 (en) Compositions and methods for monitoring the modification of natural binding partners
WO2001041794A3 (en) Activated amylase
WO2003097664A3 (en) Non-covalent inhibitors of cysteine proteases with atripeptide backbone

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP